Skip to main content

Jeff Lagasse

By Jeff Lagasse | 10:46 am | January 22, 2025
The lawsuit says Walgreens sought reimbursement for the prescriptions from various federal healthcare programs.
By Jeff Lagasse | 03:29 pm | January 21, 2025
The state is encouraging partnerships that provide strategic capital and operating support for safety-net institutions.
By Jeff Lagasse | 10:55 am | January 21, 2025
Known as Care Alliance, the partnership centers largely on imaging services and access to diagnostic care.
By Jeff Lagasse | 02:57 pm | January 17, 2025
At the center of the project is a 186,000-square-foot tower with four operating rooms and other modern features.
By Jeff Lagasse | 11:04 am | January 17, 2025
At the top of the list are the popular semaglutides for weight loss, Ozempic, Rybelsus and Wegovy.
By Jeff Lagasse | 02:53 pm | January 16, 2025
Medicaid expansion and high marketplace enrollment are contributing to the numbers, KFF says.
By Jeff Lagasse | 10:43 am | January 16, 2025
CEO Andrew Witty promises to pass through 100% of drug rebates to consumers and wants see other companies do the same.
By Jeff Lagasse | 04:02 pm | January 15, 2025
The "Big 3" PBMs also separately generated an estimated $1.4 billion of income from spread pricing, FTC finds.
By Jeff Lagasse | 10:55 am | January 15, 2025
The county plans to restore Level II trauma care immediately once it assumes hospital operations, it says.
By Jeff Lagasse | 03:39 pm | January 14, 2025
Overall, these top 25 drugs were responsible for nearly $50 billion in total Medicare Part D spending in 2022, AARP finds.